Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Standard versus tailored antiplatelet therapy in acute coronary syndrome patients undergoing percutaneous coronary angioplasty
2009-010399-10Phase 3Completed
- Sponsor
- Fondazione Monasterio
- Start
- Mar 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of clopidogrel and aspirin in acute coronary syndrome (ACS) (2 arms), sponsored by Fondazione Monasterio. Primary endpoint: Primary composite endpoint. Started Mar 2009; status: completed.
02
Drugs
clopidogrelaspirin
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on 2009-010399-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010399-10.